Public Release: 

The seventh volume of Frontiers in Clinical Drug Research -- Alzheimer Disorders

Bentham Science Publishers

The seventh volume of this series features chapters covering critical discussions on AD biochemistry and new therapies. The reviews in this volume include:

  • Deep Brain Stimulation in the Treatment of Alzheimer's disease

  • ASS234: A New and Promising Anti-Alzheimer Agent

  • Recent Advances in Alzheimer's Drug Discovery Research

  • Alzheimer's Disease and Proteasome: The Therapeutic Development and Management

  • Alzheimer´s Disease: Fundamental Concepts, Novel Findings and Therapeutics Outcomes Coming from the Ca2+/cAMP Signalling Interaction

  • Alzheimer's Disease: An Approach for Non-Pharmacological Therapies

  • Past and Present Drug Development for Alzheimer's Disease


About the Author:

Atta-ur-Rahman, Ph.D. in organic chemistry from Cambridge University (1968), has 1080 international publications in several fields of organic chemistry including 751 research publications, 37 international patents, 69 chapters in books and 221 books published largely by major U.S. and European presses. He is the Editor-in-Chief of eight European Chemistry journals. He is Editor of the world's leading encyclopedic series of volumes on natural products, Studies in Natural Product Chemistry, 54 volumes of which have been published under his Editorship by Elsevier during the last two decades.

For further information please visit:

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.